APIM Therapeutics AS is a startup based in Norway.
APIM Therapeutics AS is a startup based in Norway.
APIM Therapeutics AS is a Norwegian biotech developing peptide drugs that target PCNA-dependent stress responses in cancer cells; its lead clinical-stage candidate ATX-101 has been tested in phase Ib ovarian cancer and phase II sarcoma studies.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.